Safety Evaluation of Meningococcal Group ACYW135 Conjugate Vaccine in 2-month to 55 Years Old Population.
Clinical trial NCT04236960 · COMPLETED
Trial details
- NCT number
- NCT04236960
- Sponsor
- Walvax Biotechnology Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-17
- Primary completion
- 2019-09-16
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.